Gregory J. Tryder

Array ( [id] => 5231450 [patent_doc_number] => 20070293558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Ophthalmic Compositions for Treating Ocular Hypertension' [patent_app_type] => utility [patent_app_number] => 11/660838 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8802 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293558.pdf [firstpage_image] =>[orig_patent_app_number] => 11660838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892367 [patent_doc_number] => 07345094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Paclitaxel enhancer compounds' [patent_app_type] => utility [patent_app_number] => 11/244324 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13809 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345094.pdf [firstpage_image] =>[orig_patent_app_number] => 11244324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728371 [patent_doc_number] => 20080207915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Process for the Preparation of 2,2\'-[5-(1H-1,2,4-Triazole-1-Ylmethyl) -1,3-Phenylene] Di (2-Methylpropionitrile)' [patent_app_type] => utility [patent_app_number] => 12/088950 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3477 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207915.pdf [firstpage_image] =>[orig_patent_app_number] => 12088950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801565 [patent_doc_number] => 20060035943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => '1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease' [patent_app_type] => utility [patent_app_number] => 11/241700 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25692 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035943.pdf [firstpage_image] =>[orig_patent_app_number] => 11241700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821289 [patent_doc_number] => 20060025602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Process for making N-vinyl-2-pyrrolidone' [patent_app_type] => utility [patent_app_number] => 11/235450 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2235 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025602.pdf [firstpage_image] =>[orig_patent_app_number] => 11235450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404816 [patent_doc_number] => 07288649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst' [patent_app_type] => utility [patent_app_number] => 11/233017 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28316 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288649.pdf [firstpage_image] =>[orig_patent_app_number] => 11233017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821148 [patent_doc_number] => 20060025461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Triazole derivative' [patent_app_type] => utility [patent_app_number] => 11/232011 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19720 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025461.pdf [firstpage_image] =>[orig_patent_app_number] => 11232011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620141 [patent_doc_number] => 20060189675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Crystalline form of a drug' [patent_app_type] => utility [patent_app_number] => 11/229892 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14054 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189675.pdf [firstpage_image] =>[orig_patent_app_number] => 11229892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016645 [patent_doc_number] => 20070259854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Triazole Derivative or Salt Thereof' [patent_app_type] => utility [patent_app_number] => 11/663089 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27472 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259854.pdf [firstpage_image] =>[orig_patent_app_number] => 11663089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632400 [patent_doc_number] => 20060148870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Process for preparing olmesartan medoxomil AT pH higher than 2.5' [patent_app_type] => utility [patent_app_number] => 11/217471 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1590 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148870.pdf [firstpage_image] =>[orig_patent_app_number] => 11217471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721341 [patent_doc_number] => 20060074117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Purification of olmesartan medoxomil' [patent_app_type] => utility [patent_app_number] => 11/217352 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4127 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074117.pdf [firstpage_image] =>[orig_patent_app_number] => 11217352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270578 [patent_doc_number] => 07563814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Olmesartan medoxomil with reduced levels of impurities' [patent_app_type] => utility [patent_app_number] => 11/217473 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1489 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563814.pdf [firstpage_image] =>[orig_patent_app_number] => 11217473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739109 [patent_doc_number] => 20060009500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Antiproliferative 1,2,3-thiadiazole compounds' [patent_app_type] => utility [patent_app_number] => 11/218969 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20947 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009500.pdf [firstpage_image] =>[orig_patent_app_number] => 11218969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415314 [patent_doc_number] => 07279498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Substituted aryl amides as IP antagonists' [patent_app_type] => utility [patent_app_number] => 11/217526 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15141 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279498.pdf [firstpage_image] =>[orig_patent_app_number] => 11217526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453579 [patent_doc_number] => 07247745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Process for preparing 1,5-diaryl-3-substituted pyrazoles' [patent_app_type] => utility [patent_app_number] => 11/215329 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247745.pdf [firstpage_image] =>[orig_patent_app_number] => 11215329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711091 [patent_doc_number] => 20060052436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Pyrroloterpenes and use of the same as antimicrobial and anticancer agents' [patent_app_type] => utility [patent_app_number] => 11/205605 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12837 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052436.pdf [firstpage_image] =>[orig_patent_app_number] => 11205605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285673 [patent_doc_number] => 07550601 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-06-23 [patent_title] => 'Preparation of substituted-1,2,3-triazoles' [patent_app_type] => utility [patent_app_number] => 11/203578 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3838 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550601.pdf [firstpage_image] =>[orig_patent_app_number] => 11203578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727540 [patent_doc_number] => 20060058301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Modulators of PPAR and methods of their preparation' [patent_app_type] => utility [patent_app_number] => 11/202963 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32384 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058301.pdf [firstpage_image] =>[orig_patent_app_number] => 11202963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801602 [patent_doc_number] => 20060035950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Novel processes for preparing substantially pure anastrozole' [patent_app_type] => utility [patent_app_number] => 11/199226 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9137 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035950.pdf [firstpage_image] =>[orig_patent_app_number] => 11199226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801609 [patent_doc_number] => 20060035954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Ammonolysis process for the preparation of intermediates for DPP IV inhibitors' [patent_app_type] => utility [patent_app_number] => 11/199539 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4982 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035954.pdf [firstpage_image] =>[orig_patent_app_number] => 11199539 [rel_patent_id] =>[rel_patent_doc_number] =>)